Epithalon is a synthetic tetrapeptide derived from the pineal gland that activates telomerase — the enzyme that extends telomeres — and has been studied for over 40 years in Russian anti-aging and longevity research. It also normalizes melatonin production, improves circadian rhythm, and demonstrates antioxidant and anti-tumor effects.
This peptide profile is for research and educational purposes only. Not intended for human use or self-administration.
Overview
Epithalon (also spelled Epitalon) is a synthetic tetrapeptide (4 amino acids: Ala-Glu-Asp-Gly) derived from epithalamin — a polypeptide extract of the bovine pineal gland. Developed in the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson over four decades of research, epithalon is one of the most studied peptides in the field of anti-aging and longevity research. Its most notable documented effect is the activation of telomerase — the enzyme that extends telomeres, the protective caps on chromosomes that shorten with each cell division. In human and animal studies, epithalon has been shown to increase telomere length, slow biological aging, and reduce age-associated pathologies.
Mechanism of Action
Epithalon's primary anti-aging mechanism is the induction of telomerase (hTERT — human telomerase reverse transcriptase) activity. Telomeres naturally shorten with each cell replication cycle, eventually triggering cellular senescence or apoptosis. By activating telomerase, epithalon can extend telomere length, theoretically resetting the replicative clock of aging cells. In the pineal gland, epithalon restores melatonin production that typically declines with age, improving circadian rhythm regulation and sleep quality. It also exhibits powerful antioxidant effects, reducing lipid peroxidation and reactive oxygen species in multiple tissue types. In carcinogenesis research, epithalon has demonstrated an inhibitory effect on chemically-induced tumor development in rodent models, possibly due to its DNA-stabilizing and anti-mutagenic properties. Additionally, it normalizes the function of the hypothalamic-pituitary axis and regulates cortisol and other hormonal secretion patterns in aging models.
Key Research
Epithalon research spans 40+ years, primarily from the Institute of Bioregulation and Gerontology in St. Petersburg under Professor Vladimir Khavinson. Published studies in peer-reviewed journals document telomerase activation, telomere elongation, and life extension in mouse models. A landmark study in normal diploid human cells demonstrated that epithalon induced telomerase activity and extended telomere length, enabling cells to divide beyond their Hayflick limit. Animal longevity studies showed 30–40% increased survival compared to controls. Clinical studies in elderly patients documented improved immune function, reduced incidence of respiratory infections, normalized melatonin levels, and improved circadian rhythm. Anti-tumor effects have been documented in chemically-induced cancer models. Over 100 peer-reviewed publications support its mechanisms.
~30 minutes (rapidly distributes to pineal and other tissues
Standard research protocols use course-based administration rather than daily indefinite dosing. A typical course is 5–10 mg per day administered subcutaneously or intravenously for 10–20 consecutive days, 1–2 times per year. The most common clinical protocol used in Russian research is 10 mg/day SC for 10 days, twice yearly. Intranasal administration at 20–50 mcg per nostril has also been studied, though subcutaneous injection is considered the gold standard route. Lower-dose protocols of 5 mg/day for 20 days once or twice annually are also used. There is no established loading dose requirement. Morning or evening dosing is both acceptable — many researchers prefer morning to avoid melatonin-related drowsiness.
Classic Anti-Aging Protocol: 10 mg/day SC for 10 days, twice per year (spring and autumn). Telomere Restoration Protocol: 10 mg/day for 20 consecutive days, once annually. Combined Longevity Stack: Epithalon 10 mg/day + GHK-Cu 200 mcg/day for 20 days, twice yearly — targeting both telomere biology and collagen/tissue regeneration simultaneously.
Reported Side Effects
Side effects summarized from animal studies and researcher community observations. Educational purposes only — not medical advice.
Epithalon is one of the safest peptides in the research literature. Over 40 years of Khavinson's clinical research involving thousands of patients has documented no serious adverse events. The most commonly noted effects are dose-dependent sleepiness (particularly at evening doses, consistent with melatonin normalization), mild injection site redness, and occasional vivid dreams. Some individuals report an initial brief period of fatigue in the first few days, consistent with cellular and mitochondrial reorganization. Importantly, while epithalon activates telomerase — which could theoretically support cancer cell immortality — studies have paradoxically shown anti-tumor and tumor-suppressive effects in animal models, possibly due to its broader DNA-stabilizing effects. Nonetheless, its use is typically avoided in individuals with a history of cancer until more data is available.
Storage & Handling
Store lyophilized epithalon at -20°C for long-term storage (up to 24 months). Short-term storage at 2–8°C is acceptable for up to 3 months. Once reconstituted with bacteriostatic water, refrigerate at 2–8°C and use within 14–21 days. Epithalon is sensitive to degradation — protect from repeated temperature changes, light exposure, and air. Reconstitute gently by adding BAC water along the inside wall of the vial and swirling slowly — avoid vigorous shaking.
Age Verification Required
This site contains information about research peptides intended for adults 21 and older. By continuing you confirm you are of legal age in your jurisdiction.
By confirming below, you agree that you are at least 21 years of age and legally able to access this content in your jurisdiction.
Access Restricted
We're sorry, but you must be at least 21 years of age to access this site. This content contains research information intended for adults only.
Research Disclaimer
RESEARCH USE ONLY: All information, tools, and resources on Peptide Oracle are for educational and research purposes only.
Not Medical Advice: Nothing on this website constitutes medical advice, diagnosis, or treatment. This site does not replace professional medical consultation.
Not for Human Consumption: Peptides discussed are for laboratory and research purposes only. They are not approved for human use, consumption, or self-administration.
No Therapeutic Claims: We make no claims regarding the safety, efficacy, or therapeutic benefits of any peptides or compounds discussed.
Legal Compliance: You are responsible for compliance with all applicable local, state, and federal laws regarding peptide research and acquisition.
Limitation of Liability: Peptide Oracle assumes no liability for any damages resulting from use of information provided on this site.
Saved for 30 days. Reset by clearing browser data.
We use cookies to improve your experience and analyse site usage. By clicking Accept All you consent to our use of cookies. Cookie Policy